← Browse by Condition
Medical Condition
peritoneal neoplasms
Total Trials
2
Recruiting Now
2
Trial Phases
Phase 3
ClinicalMetric tracks all active clinical trials for peritoneal neoplasms sourced from ClinicalTrials.gov. Each listing includes the NCT identifier, current recruitment status, phase, primary endpoints, sponsor, estimated enrollment, and participating countries — updated daily as new studies open and status changes.
- Recruiting trials currently enrolling participants, with eligibility criteria and age requirements
- Phase 1–4 studies from early safety trials to post-marketing surveillance
- NIH, pharmaceutical sponsor, and academic medical center studies worldwide
- AI-powered plain-language summary available for every trial listing
Trial Phases
Phase 3 2
Top Sponsors
1 trial
1 trial
Recruiting Clinical Trials
NCT07213804 Phase 3
Recruiting
A Two-Part Phase 3 Study of Sofetabart Mipitecan (LY4170156) in Participants With Platinum-Resistant (Part A) and Platinum-Sensitive (Part B) Ovarian Cancer
Enrollment
1,080 pts
Location
United States, Austr...
Sponsor
Eli Lilly and Company
NCT04111978 Phase 3
Recruiting
MAintenance Therapy With Aromatase Inhibitor in Epithelial Ovarian Cancer (MATAO)
Enrollment
540 pts
Location
Austria, Germany, Sw...
Sponsor
Swiss GO Trial Group
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology